WPRIM Management System> DCMS> Journal of Clinical Hepatology> 2016> 32> 7

Volume: 32 Issue: 7

1. Strategy for virologic response-guided therapy in integrated diagnosis and treatment of hepatitis C in the era of precision medicine in China Page:1262—1265
2. Prognostic evaluation of primary biliary cirrhosis and its value in guiding therapeutic regimens Page:1266—1272
3. Endoscopic ultrasound and multi-slice spiral CT portal venography in diagnosis and treatment of portal hypertension Page:1273—1276
4. Clinical application of combined vascular resection and reconstruction in surgical treatment of hilar cholangiocarcinoma Page:1277—1279
5. Application of endoscopic ultrasonography in diagnosis of pancreatic cancer and related research advances Page:1280—1282
6. Establishment of a predictive model for early virologic response in previously untreated chronic hepatitis B patients treated with telbivudine Page:1287—1291
7. Association between serum level of interleukin-17 and HBsAg clearance in patients with HBeAg-negative chronic hepatitis B Page:1292—1295
8. Efficacy of low-dose glucocorticoids in treatment of HBV-related acute-on-chronic liver failure Page:1300—1304
9. Independent predictive factors for significant liver histological changes in patients with HBeAg-positive high-viral-load chronic HBV infection and a normal alanine aminotransferase level Page:1310—1314
10. Correlation between routine blood test results and antiviral effect in patients with refractory chronic hepatitis C treated with pegylated interferon-α Page:1319—1322
11. Risk genes for the development of chronic hepatitis B cirrhosis assessed by prediction analysis of microarrays Page:1323—1329
12. Effect of decoy receptor 3 gene on hepatocyte apoptosis Page:1330—1333
13. Risk factors for postoperative pulmonary infection in patients with primary liver cancer Page:1334—1337
14. Value of contrast-enhanced ultrasound in differential diagnosis of single metastatic liver cancer and solitary necrotic nodule of the liver Page:1338—1341
15. Syndrome differentiation-based treatment of primary liver cancer developed by Professor Qian Ying: an analysis of experience Page:1342—1344
16. The diagnostic value of low-frequency ultrasound combined with high-frequency ultrasound in hyperplastic of the gallbladder Page:1345—1347
17. Experience in clinical diagnosis and treatment of patients aged＞65 years with acute calculous cholecystitis Page:1348—1350
18. Recurrence after gallbladder-preserving cholecystolithotomy for sand-like and non-sand-like gallstones: a comparative analysis Page:1351—1353
19. Diagnosis, treatment, and outcome of Mirizzi syndrome in the perioperative period of laparoscopic cholecystectomy Page:1354—1356
20. Role of therapeutic endoscopic retrograde cholangiopancreatography in treatment of pancreaticobiliary diseases Page:1360—1363
21. Clinical features and risk factors for patients with liver failure complicated by invasive pulmonary aspergillosis Page:1378—1381
22. Influence of extracellular signal-regulated kinase 1/2 pathway inhibitor PD98059 on proliferation and killing function of γδT cells cultured in vitro Page:1388—1391
23. New immunotherapeutic strategies for chronic hepatitis B Page:1398—1402
24. Research advances in determination of hepatitis B core antibody level Page:1403—1405
25. Association between hepatitis B virus pre-S/S gene variants and HBV-related liver diseases Page:1406—1408
26. Research advances in liver cirrhosis complicated by portal vein thrombosis Page:1409—1412
27. Research advances in prevention and treatment of primary liver cancer with metabolic agents Page:1413—1417
28. Application of tumor-associated antigens and their autoantibodies in early diagnosis of hepatocellular carcinoma Page:1418—1421
29. Role of tumor-associated macrophages in development and progression of primary liver cancer Page:1422—1424
30. Research advances in zebrafish as a model of liver cancer Page:1425—1428
31. Research advances in sinusoidal obstruction syndrome Page:1429—1432
32. Research advances in differential diagnosis of benign and malignant ascites Page:1433—1438

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.